Genta, Inc (fka GNTAQ)

[Fourthquarter]

Just open my email and received this from GNTA.

"From: infogenta <[e-mail]>
To: [e-mail]
Subject: RE: GenasenseR


We plan to meet with the FDA regarding the recently announced appeal of
the Genasense decision in CLL. We do not comment on meeting dates,
however, we believe a final decision may be reached by FDA in the first
half of 2009.

Please refer to our recent press release (January 5th) on our website
(www.genta.com) regarding Tesetaxel receiving Orphan Drug designation.

I hope this information was of assistance to you.

Thank you for your interest in Genta."

Here is what may occure in the comming days. FDA will accept the appeal and will allow GENTA time to resubmit, buzz in the market is this news will come out this Friday (9/1) afternoon.

Any openion will be greatly appreciated.

Thank you and good luck to you all.